Esophageal cancer surgery: Standard and keyhole incisions show similar outcomes

New research has found no evidence of a difference between recovery time and complications when comparing standard and keyhole surgical incisions for the treatment of esophageal cancer (cancer of the gullet).

Gene-editing field sees another merger, this time between Chroma Medicine and Nvelop Therapeutics

Two prominent gene-editing startups, Chroma Medicine and Nvelop Therapeutics, said Wednesday they will merge, forming a new company called nChroma Bio. The merger will combine

December 11, 2024

Senate committee plans Nov. 8 vote on wide-ranging health care package

WASHINGTON — The Senate Finance Committee plans to vote Nov. 8 on legislation that includes substance abuse and mental health policies, reforms to drug middlemen’s

October 27, 2023

Nucleus RadioPharma makes Artbio’s radiopharma assets; Minaris manufactures bluebird’s Lyfgenia

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. CDMO Nucleus RadioPharma is partnering with

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.